Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Scalp psoriasis is hard to treat and may need various medications.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Phototherapy can help treat hair loss in alopecia areata.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Alopecia areata causes sudden hair loss, often resolves within a year, but can recur.

PAON shows skin patterns due to genetic mosaicism.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

People with alopecia areata have higher insulin resistance.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.